Angiodynamics, Inc. · NASDAQ:ANGO
Angiodynamics — Q2 FY2018 Earnings Presentation
9 slides from Angiodynamics's earnings presentation, Jan 4, 2018
Slide 1: Second Quarter 2018 Earnings Presentation
AngioDynamics Second Quarter 2018 Earnings Presentation January 4%, 2018 ®D angiodynamics
Slide 2: Forward-Looking Statement
2 Forward-Looking Statement Notice Regarding Forward-Looking StatementsThis presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements regarding AngioDynamics’ expected future financial position, results of operations,
Slide 3: Q2 FY2018 Highlights
Q2 FY2018 Highlights * Revenue of $86.7 million, down 2.6% year-over-year (Excluding impact of Cook Recall: Revenue down 1% year-over-year) * Adjusted EPS of $0.16, compared to $0.19 in Q2 FY17 + Adjusted EBITDAS of $13.3 million, compared to $15.2 million a year ago * Generated operating cash flow
Slide 4: Second Quarter 2018 Results
Second Quarter 2018 Results $ in millions (except per share) FY2018Q2 Results FY2017Q2 Results Change Revenue - Peripheral Vascular - Vascular Access - Oncology/Surgery - United States - International $86.751.422.612.868.318.4 $89.053.723.611.871.417.6 (3)%(4)%(4)%8%(4)%5% Net IncomeAdjusted Net Inc
Slide 5: Revised FY2018 Guidance
Revised FY2018 Guidance RevenueAdjusted EPS * Free Cash Flow ** Previous Guidance$352-$359m$0.64-$0.68$35m+ Revised Guidance$345-$350m$0.64-$0.68$30m-$35m * Excludes positive impact of statutory tax rate change from 35% to 21%.** Excludes the potential cash payment related to the DOJ legal matters d
Slide 6: GAAP to Non-GAAP Reconciliation
GAAP to Non-GAAP Reconciliation Reconciliation of GAAP to Non-GAAP Gross Profit, Net Income and EPS
Slide 7: Reconciliation of Gross Profit, Net Income and EPS
Reconiation of Gross Prt fo 00 GAAP Adjusted Gros Prot reso sam —$ 45010 aveaey charge cadet ost of sles 20 ‘Agsed goss pote tam Sem Adjusted ss roe of om Reconcation of Net Income to now GAAP Adjusted Net Income: “ee meat xd evenber 0, Novesber3, Nein os) sw sum ventory charge cet cot fle 202 Acari
Slide 8: Reconciliation of Net Income to EBITDAS to Adjusted EBITDAS
Reconciliation of Net Income to EBITDAS to Adjusted EBITDAS
Slide 9: Growth through Focus, Execution, Accountability
Growth through Focus Execution Accountablity ® angiodynamics